1. US Centers for Disease Control and Prevention (2022, May 19). Figure 3.6. Rates of Reported Acute Hepatitis C Virus Infection, by Race/Ethnicity—United States, 2004–2019. Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Viral Hepatitis Surveillance, United States, Available online: https://www.cdc.gov/hepatitis/statistics/2019surveillance/Figure3.6.htm.
2. US Centers for Disease Control and Prevention (2022, May 19). Table 3.8. Number and Rates of Deaths with Hepatitis C Virus Infection Listed as a Cause of Death Among Residents, by Demographic Characteristics—United States, 2015–2019. Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Viral Hepatitis Surveillance, United States, Available online: https://www.cdc.gov/hepatitis/statistics/2019surveillance/Table3.8.htm.
3. Roehler, D., Hoots, E., Olsen, M., Kariisa, N., Otoo Wilson, R., Rudd, D., Mustaquim, L., Xu, L., and Schieber, L. (2022, December 23). Annual Surveillance Report of Drug-Related Risks and Outcomes, United States. Centers for Disease Control and Prevention, Available online: https://www.cdc.gov/drugoverdose/pdf/pubs/2019-cdc-drug-surveillance-report.pdf.
4. Centers for Disease Control and Prevention (2022, May 19). Age-Adjusted Rates of Drug Overdose Deaths Involving Prescription Opioids, Heroin, Cocaine, and Psychostimulants with Abuse Potential, with (A) and without (B) Synthetic Opioids Other Than Methadone—United States, 2013–2019. National Vital Statistics System, Mortality File, Available online: https://www.cdc.gov/mmwr/volumes/70/wr/mm7006a4.htm?s_cid=mm7006a4_w#F1_down.
5. Trends in indicators of injection drug use, Indian Health Service, 2010–2014: A study of health care encounter data;Evans;Public Health Rep.,2020